Skip to main content

LE HR (Letrozole 2.5 mg)

Pill with imprint LE HR is Yellow, Round and has been identified as Letrozole 2.5 mg. It is supplied by Jiangsu Hengrui Pharmaceutical Co., Ltd.

Letrozole is used in the treatment of breast cancer, metastatic; breast cancer; breast cancer, adjuvant and belongs to the drug classes aromatase inhibitors, hormones/antineoplastics. There is positive evidence of human fetal risk during pregnancy. Letrozole 2.5 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for LE HR

Letrozole

Imprint
LE HR
Strength
2.5 mg
Color
Yellow
Shape
Round
Availability
Prescription only
Drug Class
Aromatase inhibitors, Hormones/antineoplastics
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Jiangsu Hengrui Pharmaceutical Co., Ltd.
National Drug Code (NDC)
57884-2021
Inactive Ingredients
lactose monohydrate, microcrystalline cellulose, sodium starch glycolate type A potato, corn starch, silicon dioxide, magnesium stearate, water, hypromellose 2910 (6 mPa.s), titanium dioxide, polyethylene glycol 400, ferric oxide red, ferrosoferric oxide

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Related images for "LE HR"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.